116 related articles for article (PubMed ID: 6658866)
21. Biosynthesis of 18-hydroxydeoxycorticosterone and corticosterone in adrenal tissue of rat strains with salt-dependent hypertension.
Wohlfeil S; Neuser D; Morich FJ
Clin Exp Hypertens A; 1988; 10(4):617-27. PubMed ID: 3390964
[TBL] [Abstract][Full Text] [Related]
22. 19-nor-deoxycorticosterone excretion in primary aldosteronism and low renin hypertension.
Griffing GT; Dale SL; Holbrook MM; Melby JC
J Clin Endocrinol Metab; 1983 Feb; 56(2):218-21. PubMed ID: 6337172
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of DOC-salt and adrenal-regeneration hypertension with the calcium blocker nifedipine.
Hall CE; Hungerford S
Clin Exp Hypertens A; 1982; 4(7):1217-30. PubMed ID: 7116665
[TBL] [Abstract][Full Text] [Related]
24. Adrenocortical factors in hypertension. I. Significance of 18-hydroxy-11-deoxycorticosterone.
Ulick S
Am J Cardiol; 1976 Nov; 38(6):814-24. PubMed ID: 187051
[TBL] [Abstract][Full Text] [Related]
25. Structural, functional and hypertensive effects of 19-oxo-11-deoxycorticosterone acetate (19-oxo-DOCA) in the rat.
Hall CE; Gomez-Sanchez CE; Hungerford S
Steroids; 1983 May; 41(5):627-35. PubMed ID: 6658894
[TBL] [Abstract][Full Text] [Related]
26. Deveolpment of hypertension in rats maintained on a sodium deficient diet and bearing a mammotropic tumor (MtTF4).
Molteni A; Nickerson PA; Latta J; Brownie AC
Virchows Arch B Cell Pathol; 1975 Nov; 19(3):191-203. PubMed ID: 813373
[TBL] [Abstract][Full Text] [Related]
27. [Adrenal regeneration hypertension--effects of vascular connective tissue protein and plasma corticosterone on hypertension in rats with adrenal regeneration hypertension].
Nakada T; Sumiya H; Shizeki Y; Shimazaki J
Nihon Hinyokika Gakkai Zasshi; 1990 Jan; 81(1):49-53. PubMed ID: 2304314
[TBL] [Abstract][Full Text] [Related]
28. 19-Hydroxylation of 18-hydroxy-11-deoxycorticosterone by adrenal mitochondria prepared from various animal species.
Momoi K; Okamoto M; Yamano T
J Steroid Biochem; 1985 Feb; 22(2):267-71. PubMed ID: 3982034
[TBL] [Abstract][Full Text] [Related]
29. Elevated 18-hydroxy-corticosterone in inbred salt-sensitive rats.
Griffing GT; Melby JC; Holbrook M; Wilson T; Azar S; Delaney M; Weiss S
Clin Exp Hypertens A; 1991; 13(3):371-82. PubMed ID: 1893610
[TBL] [Abstract][Full Text] [Related]
30. Importance of the adrenal cortex for development and maintenance of hypertension in spontaneously hypertensive rats.
Ruch W; Baumann JB; Häusler A; Otten UH; Siegl H; Girard J
Acta Endocrinol (Copenh); 1984 Mar; 105(3):417-24. PubMed ID: 6322499
[TBL] [Abstract][Full Text] [Related]
31. Parathyroidectomy significantly decreases hypertension in spontaneously hypertensive and deoxycorticosterone plus saline treated rats.
Gairard A; Berthelot A; Schleiffer R; Pernot F
Can J Physiol Pharmacol; 1982 Feb; 60(2):208-12. PubMed ID: 7083070
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the mineralocorticoid activity of 19-oxygenated and 19-nor derivatives of deoxycorticosterone.
Melby JC; Griffing GT; Holbrook M; Wilson TE; Johnston JO
Steroids; 1991 Nov; 56(11):552-7. PubMed ID: 1814021
[TBL] [Abstract][Full Text] [Related]
33. Adrenal regeneration hypertension prevented by thyroidectomy: a quantitative ultrastructural study of the regenerating adrenal cortex.
Conran RM; Nickerson PA
Am J Pathol; 1980 Aug; 100(2):411-26. PubMed ID: 7406018
[TBL] [Abstract][Full Text] [Related]
34. Steroid secretion by the enucleated rat adrenal: measurements during salt retention and the development of hypertension.
Grekin RJ; Dale SL; Gaunt R; Melby JC
Endocrinology; 1972 Nov; 91(5):1166-71. PubMed ID: 5072798
[No Abstract] [Full Text] [Related]
35. Deoxycorticosterone production in adrenal regeneration hypertension: in vitro vs. in vivo comparison.
Rapp JP
Endocrinology; 1969 Jun; 84(6):1409-20. PubMed ID: 5769380
[No Abstract] [Full Text] [Related]
36. The regulation of urinary free 19-nor-deoxycorticosterone and its relation to systemic arterial blood pressure in normotensive and hypertensive subjects.
Griffing GT; Dale SL; Holbrook MM; Melby JC
J Clin Endocrinol Metab; 1983 Jan; 56(1):99-103. PubMed ID: 6292258
[TBL] [Abstract][Full Text] [Related]
37. Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension?
Komiya I; Yamada T; Aizawa T; Takasu N; Niwa A; Maruyama Y; Ogawa A
Cardiology; 1991; 78(2):99-110. PubMed ID: 2070375
[TBL] [Abstract][Full Text] [Related]
38. The role of deoxycorticosterone in adrenal regeneration hypertension.
Brown RD; Gaunt R; Gisoldi E; Smith N
Endocrinology; 1972 Oct; 91(4):921-4. PubMed ID: 5051345
[No Abstract] [Full Text] [Related]
39. 19-nor-deoxycorticosterone: a potent mineralcocorticoid isolated from the urine of rats with regenerating adrenals.
Gomez-Sanchez CE; Holland OB; Murry BA; Lloyd HA; Milewich L
Endocrinology; 1979 Sep; 105(3):708-15. PubMed ID: 467330
[No Abstract] [Full Text] [Related]
40. Changes in the morphology and location of arterial lesions in virgin and breeder Sprague-Dawley and spontaneously hypertensive rats (SHR) to adrenal regeneration hypertension.
Wexler BC; Iams SG
Paroi Arterielle; 1980; 6(2):71-81. PubMed ID: 7232028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
